4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-013092
Director acquired 2,800 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2023-09-18 | Other acquisition 10b5-1 | +280 | $2.03 | $568 | 216,646 | D |
| Krogulski Kenneth Director | 2023-09-19 | Other acquisition 10b5-1 | +280 | $2.12 | $594 | 216,926 | D |
| Krogulski Kenneth Director | 2023-09-20 | Other acquisition 10b5-1 | +280 | $2.14 | $599 | 217,206 | D |
| Krogulski Kenneth Director | 2023-09-21 | Other acquisition 10b5-1 | +280 | $2.28 | $638 | 217,486 | D |
| Krogulski Kenneth Director | 2023-09-22 | Other acquisition 10b5-1 | +280 | $2.29 | $641 | 217,766 | D |
| Krogulski Kenneth Director | 2023-09-25 | Other acquisition 10b5-1 | +280 | $2.24 | $627 | 218,046 | D |
| Krogulski Kenneth Director | 2023-09-26 | Other acquisition 10b5-1 | +280 | $2.07 | $580 | 218,326 | D |
| Krogulski Kenneth Director | 2023-09-27 | Other acquisition 10b5-1 | +280 | $1.98 | $554 | 218,606 | D |
| Krogulski Kenneth Director | 2023-09-28 | Other acquisition 10b5-1 | +280 | $1.96 | $549 | 218,886 | D |
| Krogulski Kenneth Director | 2023-09-29 | Other acquisition 10b5-1 | +280 | $1.90 | $532 | 219,166 | D |
Loading xslF345X05/marketforms-62742.xml…